JUST IN: Covid antiviral pill can reduce hospitalizations or deaths by up to 89% among high-risk patients, Pfizer says.
or dying from the virus, that it's stopping the studies early in the hope that the general public might benefit.
“These data suggest that our oral antiviral candidate, if approved by regulatory authorities, has the potential to save patients’ lives, reduce the severity of Covid-19 infections, and eliminate up to nine out of ten hospitalizations.” Pfizer said it planned to ask the Food and Drug Administration to authorize the drug combination “as soon as possible.”
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer's COVID-19 pill, Paxlovid, cuts hospitalizations, deaths by 89%'An extraordinary effect': Pfizer says its COVID-19 pill reduced the risk of hospitalization and death by 89% in high-risk patients
Weiterlesen »
As China faces its most widespread Covid outbreak since Wuhan, officials double down on zero CovidChina is scrambling to contain its most widespread Covid-19 outbreak since the first wave of infections that began in Wuhan in 2019.
Weiterlesen »
Pfizer COVID-19 vaccine now available for kids ages 5 to 11: 5 things to knowAn 8-year-old receives his vaccine—and gets a hug from Dr. Bear—at a Washington hospital. What to know as the Pfizer COVID-19 vaccine is now available for kids ages 5 to 11:
Weiterlesen »
Pfizer says its experimental pill reduces risk of hospitalization, death from Covid-19Drugmaker Pfizer said Friday its experimental pill designed to fight coronavirus reduced the risk of hospitalization and death for high-risk patients taking part in a trial of the drug.
Weiterlesen »
Pfizer says its Covid pill with HIV drug cuts the risk of hospitalization or death by 89%Pfizer said its Covid-19 pill, used with an HIV drug, cut the risk of hospitalization or death by 89% in high-risk adults who've been exposed to the virus.
Weiterlesen »
COVID-19 vaccine campaign expands to elementary-age childrenThe U.S. enters a new phase Wednesday in its COVID-19 vaccination campaign, with shots now available to millions of elementary-age children in what health officials hailed as a major breakthrough after more than 18 months of illness, hospitalizations, deaths and disrupted education.
Weiterlesen »